Clinical TrialsSearch results
Number of results: 890
Other
- A dose finding study of melphalan combined with fludarabine as a reduced conditioning regimen for unrelated bone marrow transplantation
- Acute myeloid leukemia, Acute lymphocytic leukemia, Chronic myelogenous leukemia, Myelodysplastic syndrome,Non-Hodgkin Lymphoma, Hodgkin Lymphoma
- Nagoya Blood and Marrow Transplantation Group
- 2006-02-07
Other
- A Feasibility Trial of Tri-modality Therapy for Resectable Malignant Pleural Mesothelioma
- Malignant pleural mesothelioma
- Hyogo College of Medicine
- 2008-05-12
Other
- A genotype directed dose-finding study of Irinotecan (CPT-11) by groups of Uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphisms in patients with advanced metastatic colorectal cancer and gastric cancer.
- colorectal cancer/ gastric cancer
- Yakult Honsha Co.,Ltd
- 2006-11-01
Other
- A large prospective cohort study of cerebral microbleeds on MRI: prevalence, associations and a risk factor for stroke recurrence
- Stroke
- Department of Neurosurgery, National Hospital Organization Kumamoto Medical Center
- 2008-07-07
Other
- A long-term safety study of oral infigratinib
- Advanced solid tumors with FGF-R1 or FGF-R2 amplification FGF-R3 mutation or other FGF-R alteration.
- Ando Yuichi
- 2018-12-12
Other
- A multi institutional phase II study of oral fludarabine and rituximab (F-R therapy) for patients with relapsed or refractory mantle cell lymphoma.
- Mantle cell lymphoma
- Hematological Malignancy Clinical Study Group
- 2008-10-11
Other
- A multi institutional phase II trial of peripheral blood stem cell transplantation for adult T cell leukemia/lymphoma following reduced intensity conditioning regimen.
- Adult T cell leukemia/lymphoma
- Grant for anticancer project from Ministry of Health, Welfare, and Labor of Japan
- 2006-05-01
Other
- A multicenter phase II open-label study in untreated patients with CD20 positive indolent B-cell non-Hodgkin's lymphoma evaluating efficacy and safety of maintenance therapy with IDEC-C2B8.
- Untreated patients with CD20 positive indolent B-cell non-Hodgkin's lymphoma.
- Zenyaku Kogyo Co., Ltd.
- 2008-12-26
Other
- A multicenter phase II study of FOLFIRI as first-line chemotherapy for metastatic colorectal cancer with reduced starting dose of irinotecan in patients with homozygous for UGT1A1(FLIGHT1)
- colorectal cancer
- NPO Epidemiological and Clinical Research Information Network
- 2009-09-01
Other
- A multicenter phaseII study of FOLFIRI as FOLFOX refractory second-line chemotherapy for metastatic colorectal cancer with reduced starting dose of irinotecan in patients with honozygous for UGT1A1: (FLIGHT2)
- colorectal cancer
- NPO Epidemiological and Clinical Research Information Network
- 2009-09-10